Has Xiaoying Deng, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,625 in general payments to Xiaoying Deng, MD across 34 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Xiaoying Deng, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Xiaoying Deng, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Xiaoying Deng, MD

Nephrology · Fargo, NDNPI 1649463647

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,600 of the $5,625 with a category attached, or 64.0%. Travere Therapeutics, Inc. accounts for 75.9% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $4,581, more than ten times the $197 reported in 2019. Among nephrology clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,625in general payments, 2019–2025

Across 34 payments — averaging $165.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Travere Therapeutics, Inc.$4K
GSK$226
Mallinckrodt Enterprises LLC$197
Corcept Therapeutics$147
Vantive US Healthcare LLC$128
Amgen$128
plus $529 from 8 others

$28,200in research payments, 2019–2025

Across 4 payments — averaging $7050.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Takeda Pharmaceuticals U.S.A., Inc.$28K

What the payments were for

Consulting fees$3,60064%
Travel & lodging$2785%
Food & beverage$1,67230%
Education$751%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Travere Therapeutics, Inc.	12	$4,269
GSK	2	$226
Mallinckrodt Enterprises LLC	2	$197
Corcept Therapeutics	2	$147
Vantive US Healthcare LLC	1	$128
Amgen(2 entities)	3	$128
Calliditas Therapeutics US Inc.	2	$123
Ardelyx, Inc.	1	$108
Bard Peripheral Vascular, Inc.	2	$92
Sanofi	1	$89
Nxstage Medical, Inc.	2	$39
Otsuka America Pharmaceutical, Inc.	2	$37
Apellis Pharmaceuticals, Inc.	1	$22
Baxter Healthcare	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,625 in reported general payments places this provider in the 95th percentile of 22 nephrology providers in North Dakota.

See all nephrology providers in North Dakota →

Medicare billing

Part B allowed, 2024

$90,761

Medicare patients

271

Services billed

683

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	140	$177,435
OzempicSemaglutide	76	$116,986
FarxigaDapagliflozin Propanediol	72	$52,975
LokelmaSodium Zirconium Cyclosilicate	14	$12,791
Lanthanum Carbonate	11	$8,612
Calcitriol	245	$7,343
Sevelamer Carbonate	25	$5,008
Calcium Acetate	59	$4,860
ProsolParenteral Amino Acid 20% No.1	21	$3,611
Torsemide	56	$2,499
Potassium Citrate ErPotassium Citrate	18	$1,862
Losartan Potassium	171	$1,712
Tamsulosin Hcl	119	$1,669
Amlodipine Besylate	172	$1,613
Chlorthalidone	85	$1,485

Paid to pharmacies, not to this prescriber.

Other nephrology in Fargo

Jeffrey SkogenFargo$58K
Lakshmi PathakFargo$1K
Ashish RegulagaddaFargo$955
Hassan AttiqueFargo$679
Eram ShahiraFargo$530
Harminder SinghFargo$179
Inna MalostovkerFargo$86
Marwan Abu MinsharFargo$62
Daniel LouvarFargo$16
Tinika MontgomeryFargo$3

See the full list for North Dakota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →